At the same time, we demonstrated that the expression of AKR1B10 in TNM stage III–IV patients or patients with lymph node metastasis was lower than that in control group in a significant way. This evidence concerns the gene AKR1B10 and metastatic malignant neoplasm in the lymph nodes.